KEY FINDINGS
The Germany peripheral artery disease market is anticipated to register a CAGR of 10.78% during the forecasting years. The market growth of the country is facilitated by key factors, including the rising geriatric population, the increasing adoption of new technologies within the healthcare industry, and the surging incidence of peripheral artery disease. While the base year considered for the market study is 2020, the reviewed period is from 2021 to 2026.
MARKET INSIGHTS
The aging population continues to augment worldwide. According to a World Health Organization (WHO) report, in 2019, nearly 125 million people were above the age of 80, and this figure is anticipated to reach 2 billion over the next three decades. As a result, the geriatric population is projected to constitute approximately 16% of the global population by 2050. Moreover, a positive correlation exists between elderly individuals as well as the growing prevalence of diseases like hypertension and diabetes. This factor, in turn, increases the risk of peripheral artery diseases.
In Germany, the adoption of new technology within the healthcare sector is higher and more rapid compared to the majority of European countries. This is primarily attributed to the increasing number of international healthcare companies. According to the report titled, ‘German Guideline on the Diagnosis and Treatment of Peripheral Artery Disease - A Comprehensive Update 2016,’ the incidence of peripheral artery diseases continues to increase globally and is strongly age-related. As a result, the condition affects approximately 20% of Germans above the age of 70. Hence, these factors are credited to the market growth in Germany over the forecasting period.
COMPETITIVE INSIGHTS
Some of the leading companies operating in the market are Bayer AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments